More extensive deployment of existing methods for measuring T-cell immunity to SARS-CoV-2 could provide a more complete profile of the immune status for at risk populations and offer insights for informing public health interventions. Read @SciImmunology: https://t.co/VNg5dxiKZl
It was an honor to sit down with @MedicalWrldNews for a discussion of findings from our recent @Nature article on the T-cell response generated by the J&J (@JNJNews) COVID-19 vaccine to #COVID19 variants.
As new variants spread, many are wondering how effective current #COVID19 vaccines will continue to be. CMO @LanceBaldoMD shares insights from a @Nature paper on how measuring T-cells can answer these questions and more. Watch the interview at https://t.co/yELu4eWvgZ.
Data science never mattered so much as it does now. Grateful for the opportunity to partner with @Microsoft and hear the diversity of perspectives on the future of big data in medicine.
Congratulations to our partners at @microsoft on their brilliant new Resilience series highlighting the community response to #COVID19 and the role science and technology have played in the pandemic. https://t.co/gotGfkK9h3 #SocietalResilience#Got2Adapt
@dianaberrent@Polar20964877@mplancelotta@AdaptiveBiotech We do not currently have information on how the vaccine may affect the T-Detect test results, but we are seeing through our research tool that we are able distinguish between T-cell responses to vaccines and natural infection.
2/3